Home
The
Founding Team

CANTREAT represents a new era in cancer therapy: precise, effective, and well-tolerated.

Mag. Thomas Steinmüller

CEO, Finance, Risk & Project Management, Chairman of the Board

Ing. Dietmar Hold

CCO, Investor Relations, Company Spokesperson, Delegate of the Board of Directors

DI Michael Forster

CTO, Head of Research & Technical Development, Member of the Board of Directors

Mag. Thomas Steinmüller

CEO, Finance, Risk & Project Management, Chairman of the Board

ING. Dietmar Hold

CCO, Investor Relations, Company Spokesperson, Delegate of the Board of Directors

DI Michael Forster

CTO, Head of Research & Technical Development, Member of the Board of Directors